TY - JOUR
T1 - General practitioners’ attitude toward early and pre-dementia diagnosis of ad in five European countries—a mopead project survey
AU - Sannemann, Lena
AU - Müller, Theresa
AU - Waterink, Lisa
AU - Zwan, Marissa
AU - Wimo, Anders
AU - Stomrud, Erik
AU - Pinó, Susana
AU - Arrufat, Jordi
AU - Rodríguez-Gomez, Octavio
AU - Benaque, Alba
AU - Bon, Jaka
AU - Ferreira, Daniel
AU - Johansson, Gunilla
AU - Dron, Amanda
AU - Dumas, Annette
AU - Georges, Jean
AU - Kramberger, Milica G.
AU - Visser, Pieter Jelle
AU - Winblad, Bengt
AU - Campo, Laura
AU - Boada, Mercè
AU - Jessen, Frank
AU - MOPEAD consortium
PY - 2021
Y1 - 2021
N2 - Introduction: General practitioners (GPs) play a key role in early identification of dementia, yet diagnosis is often missed or delayed in primary care. As part of the multinational Models of Patient Engagement for Alzheimer’s Disease project, we assess GPs’ attitude toward early and pre-dementia diagnosis of AD and explore barriers to early diagnosis. Methods: Our survey covered general attitude toward early diagnosis, diagnostic procedures, resources, and opinion on present and future treatment options across five European countries. Results: In total 343 GPs completed the survey; 74% of GPs indicated that an early diagnosis is valuable. There were country-specific differences in GPs’ perceptions of reimbursement and time available for the patient. If a drug were available to slow down the progression of AD, 59% of the GPs would change their implementation of early diagnosis. Discussion: Our findings provide insight into GPs’ attitudes by exploring differences in perception and management of early diagnosis.
AB - Introduction: General practitioners (GPs) play a key role in early identification of dementia, yet diagnosis is often missed or delayed in primary care. As part of the multinational Models of Patient Engagement for Alzheimer’s Disease project, we assess GPs’ attitude toward early and pre-dementia diagnosis of AD and explore barriers to early diagnosis. Methods: Our survey covered general attitude toward early diagnosis, diagnostic procedures, resources, and opinion on present and future treatment options across five European countries. Results: In total 343 GPs completed the survey; 74% of GPs indicated that an early diagnosis is valuable. There were country-specific differences in GPs’ perceptions of reimbursement and time available for the patient. If a drug were available to slow down the progression of AD, 59% of the GPs would change their implementation of early diagnosis. Discussion: Our findings provide insight into GPs’ attitudes by exploring differences in perception and management of early diagnosis.
KW - Alzheimer’s disease
KW - Dementia
KW - Early diagnosis
KW - General practitioners
KW - Mild cognitive impairment
KW - Primary care
U2 - 10.1002/dad2.12130
DO - 10.1002/dad2.12130
M3 - Article
C2 - 33665337
AN - SCOPUS:85108259681
SN - 2352-8729
VL - 13
JO - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
JF - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
IS - 1
M1 - e12130
ER -